Nanosonics (ASX: NAN) — Stock Profile

About Nanosonics (ASX: NAN)

Nanosonics Limited is an infection prevention company that manufactures, distributes, and commercialises infection control and decontamination products and related technologies across Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company's core focus spans the development of ultrasound probe disinfection systems alongside their associated consumables, accessories, and supporting digital infrastructure.

Its principal product line centres on the trophon family of ultrasound probe disinfectors, which includes the trophon EPR, a device built around patented sonicated mist technology capable of providing high level disinfection of both endocavitary and surface ultrasound probes, and the trophon2, an enhanced iteration offering new functionality through AcuTrace, a tool designed for audit-ready digital record-keeping and integration with hospital IT systems. The company also offers AuditPro, an infection control workflow compliance management solution, and CORIS, an instrument reprocessing product platform. Incorporated in 2000, Nanosonics is headquartered in Macquarie Park, Australia.

MFAM Research

  • [BUY] Nanosonics (ASX:NAN) to Benefit from COVID Normalisation and Market Expansion
    May 12, 2021
    Today we will look at why we like Nanosonics shares (ASX:NAN) and some analysis on our NAN share price forecast. Nanosonics is a producer of HLD (High-Level Disinfection) medical equipment. The company’s products are mainly used in the disinfection of ultrasound probes. Nanosonics shares (ASX:NAN) has had a rocky 15 months due to the reduced […]
Our Exclusive Top 5 Stock Picks

Five high conviction stocks that didn't make the public list. Backed by institutional research with significant upside potential. Subscribe for free access.

Invalid email address
By subscribing, you consent to receive communications from us. You can unsubscribe at any time.

Latest Announcements

  • Nanosonics (ASX: NAN) – 2026 Full Year Financial Results
    August 25, 2026
    Nanosonics delivered FY26 results that highlight the enduring strength of its trophon franchise while setting the stage for a significant inflection point with the planned commercialisation of its CORIS system in the first half of FY27. The core message from management is one of disciplined execution on the proven trophon business combined with confidence in […]
  • Nanosonics (ASX: NAN) – Nanosonics Files Full 2026 Annual Report
    August 25, 2026
    Nanosonics is entering a new phase of growth with the commercial launch of CORIS, its second major platform product, marking the most significant transformation since establishing trophon as the standard for ultrasound probe disinfection. The company’s FY26 results show solid fundamentals underpinning this expansion, with revenue reaching $203.9 million, up 3 percent year-on-year and 6 […]
  • Nanosonics (ASX: NAN) – Files 2026 Preliminary Financial Report
    August 25, 2026
    I need the Nanosonics announcement text to write the commentary. The announcement section in your message came through empty. Could you paste the full announcement text, or point me to where it is in the Office? Once I have the details, I’ll write the 400-500 word analyst piece following your style guidelines. View the full […]

Financial Summary

Price History

Same Industry — HealthcareSame Sub-Industry — Medical Instruments & Supplies
Share This